Imatinib NEW
Price | Get Latest Price | ||
Package | 1Gram | 5Gram | 25Gram |
Min. Order: | 1Gram |
Supply Ability: | 100KG |
Update Time: | 2024-11-01 |
Related documents: | COA |
Product Details
Product Name: Imatinib | CAS No.: 152459-95-5 |
EC-No.: 604-855-6 | Min. Order: 1Gram |
Purity: USP, BP | Supply Ability: 100KG |
Release date: 2024/11/01 | |
Appearance:: White powder | Shelf Life:: 2 years |
Description:
Imatinib is a medication that belongs to a class of drugs known as tyrosine kinase inhibitors. Here is an introduction to Imatinib, including its uses:
Medical Uses:
Imatinib is primarily used in the treatment of certain types of cancers, particularly leukemia and gastrointestinal stromal tumors (GIST). It is also effective in treating other cancers such as chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
Chronic Myeloid Leukemia (CML):
Imatinib is a first-line treatment for CML, a type of cancer that affects the bone marrow and blood. It works by specifically targeting and inhibiting the activity of the BCR-ABL fusion protein, which is characteristic of CML cells. By blocking this abnormal protein, Imatinib helps to control the growth and division of cancer cells.
Gastrointestinal Stromal Tumors (GIST):
Imatinib is also used in the treatment of GIST, a type of tumor that originates in the gastrointestinal tract. It targets and inhibits specific proteins, such as KIT and PDGFRA, which are often mutated in GIST cells. By blocking these proteins, Imatinib helps to slow down or stop the growth of GIST tumors.
Acute Lymphoblastic Leukemia (ALL):
Imatinib may be used in the treatment of certain cases of ALL, a type of blood cancer that affects the lymphoid cells. In some instances, Imatinib may be prescribed as part of a combination therapy to target specific genetic abnormalities in the cancer cells.
Other Conditions:
Imatinib has also shown promise in the treatment of other conditions, such as dermatofibrosarcoma protuberans (a rare type of skin cancer), myelodysplastic/myeloproliferative diseases, and systemic mastocytosis.
Side Effects:
Like all medications, Imatinib can cause side effects, which may vary from person to person. Common side effects may include nausea, vomiting, diarrhea, muscle cramps, fatigue, and fluid retention.
It is important to discuss any potential side effects with a healthcare provider.
Imatinib has been a significant advancement in the treatment of certain types of cancers, offering improved outcomes and quality of life for many patients.
It is crucial to use Imatinib under the supervision of a healthcare professional to ensure proper dosing and monitoring during treatment.
Product Forms: Injectable Solution, Oral Capsules/Tablets
Payment method: T/T in advance, Paypal, Western Union, L/C, etc.
Shipping ways: Courier, Air, Sea, Road
Storage Condition: Dry, dark, and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$79.00/500mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-10-31 | |
$0.00/1kg |
VIP2Y
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-09-11 | |
$19.10/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
$999.00/10kg |
VIP1Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-08 | |
$8.00/1KG |
VIP1Y
|
Henan Fengda Chemical Co., Ltd
|
2024-03-28 | |
$0.00/1kg |
VIP1Y
|
Nanjing Fred Technology Co., Ltd
|
2023-12-06 | |
$0.00/25Kg/Bag |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2023-10-18 | |
$0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-09-01 | |
$100.00/1mg |
Shijiazhuang Gantuo Biotechnology Co., Ltd
|
2023-03-10 | ||
$200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-11-27 |
- Since: 2013-11-01
- Address: Room 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Road, Gongshu District, Hangzhou, Z
+86-13675893055
info@hyper-chem.com